A detailed history of Transcendent Capital Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Transcendent Capital Group LLC holds 123 shares of AMGN stock, worth $38,979. This represents 0.02% of its overall portfolio holdings.

Number of Shares
123
Previous 268 54.1%
Holding current value
$38,979
Previous $83.9 Million 52.83%
% of portfolio
0.02%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$309.38 - $337.38 $44,860 - $48,920
-145 Reduced 54.1%
123 $39.6 Million
Q2 2024

Jul 24, 2024

SELL
$262.75 - $319.31 $2,102 - $2,554
-8 Reduced 2.9%
268 $83.9 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $1,613 - $1,947
-6 Reduced 2.13%
276 $78.5 Million
Q4 2023

Mar 01, 2024

BUY
$255.7 - $288.46 $72,107 - $81,345
282 New
282 $81.1 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Transcendent Capital Group LLC Portfolio

Follow Transcendent Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcendent Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcendent Capital Group LLC with notifications on news.